Ballentine Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $473K | Buy |
|
|||||
|
2025
Q2 | $475K | Buy |
|
|||||
|
2025
Q1 | $370K | Sell |
|
|||||
|
2024
Q4 | $406K | Buy |
|
|||||
|
2024
Q3 | $308K | Sell |
|
|||||
|
2024
Q2 | $494K | Buy |
|
|||||
|
2024
Q1 | $500K | Buy |
|
|||||
|
2023
Q4 | $324K | Sell |
|
|||||
|
2023
Q3 | $352K | Sell |
|
|||||
|
2023
Q2 | $533K | Buy |
|
|||||
|
2023
Q1 | $452K | Buy |
|
|||||
|
2022
Q4 | $366K | Buy |
|
|||||
|
2022
Q3 | $333K | Buy |
|
|||||
|
2022
Q2 | $288K | Buy |
|
|||||
|
2022
Q1 | $252K | Buy |
|
|||||
|
2021
Q4 | $242K | Buy |
|
|||||
|
2021
Q3 | $211K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $355K | Sell |
|
|||||
|
2020
Q2 | $374K | Buy |
|
|||||
|
2020
Q1 | $335K | Sell |
|
|||||
|
2019
Q4 | $437K | Hold |
|
|||||
|
2019
Q3 | $412K | Buy |
|
|||||
|
2019
Q2 | $323K | Buy |
|
|||||
|
2019
Q1 | $243K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $260K | Sell |
|
|||||
|
2016
Q2 | $222K | Buy |
|